These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1023 related articles for article (PubMed ID: 9002287)

  • 41. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan.
    Muta H; Ishii M; Egami K; Furui J; Sugahara Y; Akagi T; Nakamura Y; Yanagawa H; Matsuishi T
    J Pediatr; 2004 Apr; 144(4):496-9. PubMed ID: 15069399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease.
    Muta H; Ishii M; Furui J; Nakamura Y; Matsuishi T
    Acta Paediatr; 2006 Feb; 95(2):189-93. PubMed ID: 16449025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Epidemiologic features of Kawasaki disease].
    Nakamura Y
    Nihon Rinsho; 2008 Feb; 66(2):229-34. PubMed ID: 18260319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome.
    Hsu CH; Chen MR; Hwang FY; Kao HA; Hung HY; Hsu CH
    Pediatr Infect Dis J; 1993 Jun; 12(6):509-12. PubMed ID: 8345983
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiologic picture of Kawasaki disease in Korea, 2000-2002.
    Park YW; Han JW; Park IS; Kim CH; Yun YS; Cha SH; Ma JS; Lee SB; Kim CH; Lee HJ; Tockgo YC
    Pediatr Int; 2005 Aug; 47(4):382-7. PubMed ID: 16091073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiological survey of Kawasaki disease in Sichuan province of China.
    Li XH; Li XJ; Li H; Xu M; Zhou M
    J Trop Pediatr; 2008 Apr; 54(2):133-6. PubMed ID: 17965438
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mass survey for coronary lesions in school children with history of Kawasaki disease in Shimane Prefecture.
    Haneda N; Kajino Y; Saito M; Watanabe K; Nishio T; Mori C; Kijima Y; Nagaoka S
    Jpn Circ J; 1985 Dec; 49(12):1280-4. PubMed ID: 3831396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and clinical features of incomplete Kawasaki disease.
    Fukushige J; Takahashi N; Ueda Y; Ueda K
    Acta Paediatr; 1994 Oct; 83(10):1057-60. PubMed ID: 7841704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of Kawasaki disease in the British Isles.
    Dhillon R; Newton L; Rudd PT; Hall SM
    Arch Dis Child; 1993 Dec; 69(6):631-6; discussion 637-8. PubMed ID: 8285773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical features of patients with Kawasaki disease whose parents had the same disease.
    Uehara R; Yashiro M; Nakamura Y; Yanagawa H
    Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1166-9. PubMed ID: 15583102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kawasaki disease in parents and children.
    Uehara R; Yashiro M; Nakamura Y; Yanagawa H
    Acta Paediatr; 2003 Jun; 92(6):694-7. PubMed ID: 12856980
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiologic aspects of Kawasaki disease in a Manhattan hospital.
    Ichida F; Fatica NS; O'Loughlin JE; Klein AA; Snyder MS; Levin AR; Ehlers KH; Lesser ML; Engle MA
    Pediatrics; 1989 Aug; 84(2):235-41. PubMed ID: 2748250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nationwide survey of Kawasaki disease and acute rheumatic fever.
    Taubert KA; Rowley AH; Shulman ST
    J Pediatr; 1991 Aug; 119(2):279-82. PubMed ID: 1861216
    [No Abstract]   [Full Text] [Related]  

  • 55. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan.
    Hirata S; Nakamura Y; Yanagawa H
    Acta Paediatr; 2001 Jan; 90(1):40-4. PubMed ID: 11227331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimation of the incidence of Kawasaki disease in Taiwan. A comparison of two data sources: nationwide hospital survey and national health insurance claims.
    Lue HC; Chen LR; Lin MT; Chang LY; Wang JK; Lee CY; Wu MH
    Pediatr Neonatol; 2014 Apr; 55(2):97-100. PubMed ID: 23890670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac sequelae of Kawasaki disease in Japan over 10 years.
    Hirose K; Nakamura Y; Yanagawa H
    Acta Paediatr Jpn; 1995 Dec; 37(6):667-71. PubMed ID: 8775548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. National Japanese survey of thrombolytic therapy selection for coronary aneurysm: intracoronary thrombolysis or intravenous coronary thrombolysis in patients with Kawasaki disease.
    Harada M; Akimoto K; Ogawa S; Kato H; Nakamura Y; Hamaoka K; Saji T; Shimizu T; Kato T
    Pediatr Int; 2013 Dec; 55(6):690-5. PubMed ID: 23919576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Cardiac manifestations in the acute phase of Kawasaki disease in a third level children's hospital in Mexico City].
    Garrido-García LM; Peña-Juárez RA; Yamazaki-Nakashimada MA
    Arch Cardiol Mex; 2018 Dec; 88(5):441-446. PubMed ID: 29650328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kawasaki Disease and Pediatric Infectious Diseases During the Coronavirus Disease 2019 Pandemic.
    Ae R; Shibata Y; Kosami K; Nakamura Y; Hamada H
    J Pediatr; 2021 Dec; 239():50-58.e2. PubMed ID: 34324881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.